Super Phosphozyme Liquid
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 100% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
1.5 mL
Serving Size
40
Servings
Mineral
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
40 mg
(4% DV)
✅ Within RDA (0.1× RDA of 700 mg)
📚 12 studies (Tier A: 0, B: 3)
Other Ingredients
purified Water
orthophosphoric acid
Inositol
Riboflavin
Ingredients
Label Claims — Verification
❓
All Other
All Other (98% of products)
Structure/Function (89% of products)
Nutrient (76% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
RECOMMENDATION: Thirty (30) drops in water each day as a dietary supplement or as otherwise directed by a healthcare professional.
⚠️ Warnings & Precautions
Sealed with an imprinted safety seal for your protection.
KEEP OUT OF REACH OF CHILDREN
Additional Information
Store in a cool, dry area away from direct light.
Rev. 5/06
34001A APR 12
Product Details
Research Evidence
46
Research Sources
55
Avg Quality Score
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
B
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
B
Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
B
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
B
Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
B
The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Compare Similar Products
Ultimate Phosphorus Concentrate
Complete H2O Minerals
100
AdenoPlus
Nutrasal
100
Ionic Phosphorus 50,000 PPM
Good State
100
Phosfood Liquid
SP Standard Process
100
Phosfood Liquid
SP Standard Process
100